-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011, 61:69-90.
-
(2011)
CA: A Cancer Journal for Clinicians
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
84872967522
-
Cancer statistics, 2013
-
Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 2013, 63:11-30.
-
(2013)
CA: A Cancer Journal for Clinicians
, vol.63
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
3
-
-
84859424193
-
The role of molecular analyses in the era of personalized therapy for advanced NSCLC
-
Tanner N.T., Pastis N.J., Sherman C., Simon G.R., Lewin D., Silvestri G.A. The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer 2012, 76:131-137.
-
(2012)
Lung Cancer
, vol.76
, pp. 131-137
-
-
Tanner, N.T.1
Pastis, N.J.2
Sherman, C.3
Simon, G.R.4
Lewin, D.5
Silvestri, G.A.6
-
6
-
-
84862882003
-
Tumor immunotherapy directed at PD-1
-
Ribas A. Tumor immunotherapy directed at PD-1. New England Journal of Medicine 2012, 366:2517-2519.
-
(2012)
New England Journal of Medicine
, vol.366
, pp. 2517-2519
-
-
Ribas, A.1
-
7
-
-
77955883153
-
Complement: a key system for immune surveillance and homeostasis
-
Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nature Immunology 2010, 11:785-797.
-
(2010)
Nature Immunology
, vol.11
, pp. 785-797
-
-
Ricklin, D.1
Hajishengallis, G.2
Yang, K.3
Lambris, J.D.4
-
8
-
-
66549124166
-
Is complement good or bad for cancer patients? A new perspective on an old dilemma
-
Markiewski M.M., Lambris J.D. Is complement good or bad for cancer patients? A new perspective on an old dilemma. Trends in Immunology 2009, 30:286-292.
-
(2009)
Trends in Immunology
, vol.30
, pp. 286-292
-
-
Markiewski, M.M.1
Lambris, J.D.2
-
9
-
-
70349437186
-
Complement regulators and inhibitory proteins
-
Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nature Reviews Immunology 2009, 9:729-740.
-
(2009)
Nature Reviews Immunology
, vol.9
, pp. 729-740
-
-
Zipfel, P.F.1
Skerka, C.2
-
10
-
-
0030480250
-
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
-
Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Research 1996, 56:5309-5318.
-
(1996)
Cancer Research
, vol.56
, pp. 5309-5318
-
-
Hakomori, S.1
-
11
-
-
0347123435
-
Mucins in cancer: protection and control of the cell surface
-
Hollingsworth M.A., Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nature Reviews Cancer 2004, 4:45-60.
-
(2004)
Nature Reviews Cancer
, vol.4
, pp. 45-60
-
-
Hollingsworth, M.A.1
Swanson, B.J.2
-
12
-
-
26844461245
-
'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis
-
Costello L.C., Franklin R.B. 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis. Molecular and Cellular Biochemistry 2005, 280:1-8.
-
(2005)
Molecular and Cellular Biochemistry
, vol.280
, pp. 1-8
-
-
Costello, L.C.1
Franklin, R.B.2
-
13
-
-
33750435528
-
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
-
Glunde K., Serkova N.J. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 2006, 7:1109-1123.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 1109-1123
-
-
Glunde, K.1
Serkova, N.J.2
-
14
-
-
33748171538
-
The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans
-
Chandrasekaran E.V., Xue J., Neelamegham S., Matta K.L. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Carbohydrate Research 2006, 341:983-994.
-
(2006)
Carbohydrate Research
, vol.341
, pp. 983-994
-
-
Chandrasekaran, E.V.1
Xue, J.2
Neelamegham, S.3
Matta, K.L.4
-
15
-
-
84863767717
-
Altered expression of sialidases in human cancer
-
Miyagi T., Takahashi K., Moriya S., Hata K., Yamamoto K., Wada T., et al. Altered expression of sialidases in human cancer. Advances in Experimental Medicine and Biology 2012, 749:257-267.
-
(2012)
Advances in Experimental Medicine and Biology
, vol.749
, pp. 257-267
-
-
Miyagi, T.1
Takahashi, K.2
Moriya, S.3
Hata, K.4
Yamamoto, K.5
Wada, T.6
-
16
-
-
0042470540
-
Does the immune system see tumors as foreign or self?
-
Pardoll D. Does the immune system see tumors as foreign or self?. Annual Review of Immunology 2003, 21:807-839.
-
(2003)
Annual Review of Immunology
, vol.21
, pp. 807-839
-
-
Pardoll, D.1
-
17
-
-
0035320526
-
A fresh look at tumor immunosurveillance and immunotherapy
-
Smyth M.J., Godfrey D.I., Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunology 2001, 2:293-299.
-
(2001)
Nature Immunology
, vol.2
, pp. 293-299
-
-
Smyth, M.J.1
Godfrey, D.I.2
Trapani, J.A.3
-
18
-
-
79953151458
-
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
-
Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
-
(2011)
Science
, vol.331
, pp. 1565-1570
-
-
Schreiber, R.D.1
Old, L.J.2
Smyth, M.J.3
-
19
-
-
0018179389
-
Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells
-
McConnell I., Klein G., Lint T.F., Lachmann P.J. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. European Journal of Immunology 1978, 8:453-458.
-
(1978)
European Journal of Immunology
, vol.8
, pp. 453-458
-
-
McConnell, I.1
Klein, G.2
Lint, T.F.3
Lachmann, P.J.4
-
20
-
-
0026780644
-
Persistent complement activation on tumor cells in breast cancer
-
Niculescu F., Rus H.G., Retegan M., Vlaicu R. Persistent complement activation on tumor cells in breast cancer. American Journal of Pathology 1992, 140:1039-1043.
-
(1992)
American Journal of Pathology
, vol.140
, pp. 1039-1043
-
-
Niculescu, F.1
Rus, H.G.2
Retegan, M.3
Vlaicu, R.4
-
21
-
-
0029829738
-
Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma
-
Lucas S.D., Karlsson-Parra A., Nilsson B., Grimelius L., Akerstrom G., Rastad J., et al. Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma. Human Pathology 1996, 27:1329-1335.
-
(1996)
Human Pathology
, vol.27
, pp. 1329-1335
-
-
Lucas, S.D.1
Karlsson-Parra, A.2
Nilsson, B.3
Grimelius, L.4
Akerstrom, G.5
Rastad, J.6
-
22
-
-
0029896853
-
Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins
-
Gasque P., Thomas A., Fontaine M., Morgan B.P. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins. Journal of Neuroimmunology 1996, 66:29-40.
-
(1996)
Journal of Neuroimmunology
, vol.66
, pp. 29-40
-
-
Gasque, P.1
Thomas, A.2
Fontaine, M.3
Morgan, B.P.4
-
23
-
-
33847255420
-
Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells
-
Bu X., Zheng Z., Wang C., Yu Y. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells. Pathology, Research and Practice 2007, 203:163-167.
-
(2007)
Pathology, Research and Practice
, vol.203
, pp. 163-167
-
-
Bu, X.1
Zheng, Z.2
Wang, C.3
Yu, Y.4
-
24
-
-
0033368042
-
Complement resistance of tumor cells: basal and induced mechanisms
-
Jurianz K., Ziegler S., Garcia-Schuler H., Kraus S., Bohana-Kashtan O., Fishelson Z., et al. Complement resistance of tumor cells: basal and induced mechanisms. Molecular Immunology 1999, 36:929-939.
-
(1999)
Molecular Immunology
, vol.36
, pp. 929-939
-
-
Jurianz, K.1
Ziegler, S.2
Garcia-Schuler, H.3
Kraus, S.4
Bohana-Kashtan, O.5
Fishelson, Z.6
-
25
-
-
0033486076
-
Immune evasion of tumor cells using membrane-bound complement regulatory proteins
-
Gorter A., Meri S. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunology Today 1999, 20:576-582.
-
(1999)
Immunology Today
, vol.20
, pp. 576-582
-
-
Gorter, A.1
Meri, S.2
-
26
-
-
0041563779
-
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors
-
Fishelson Z., Donin N., Zell S., Schultz S., Kirschfink M. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Molecular Immunology 2003, 40:109-123.
-
(2003)
Molecular Immunology
, vol.40
, pp. 109-123
-
-
Fishelson, Z.1
Donin, N.2
Zell, S.3
Schultz, S.4
Kirschfink, M.5
-
27
-
-
58149357133
-
The role of membrane complement regulatory proteins in cancer immunotherapy
-
Yan J., Allendorf D.J., Li B., Yan R., Hansen R., Donev R. The role of membrane complement regulatory proteins in cancer immunotherapy. Advances in Experimental Medicine and Biology 2008, 632:159-174.
-
(2008)
Advances in Experimental Medicine and Biology
, vol.632
, pp. 159-174
-
-
Yan, J.1
Allendorf, D.J.2
Li, B.3
Yan, R.4
Hansen, R.5
Donev, R.6
-
28
-
-
68049135726
-
Cancer resistance to complement-dependent cytotoxicity (CDC): problem-oriented research and development
-
Gancz D., Fishelson Z. Cancer resistance to complement-dependent cytotoxicity (CDC): problem-oriented research and development. Molecular Immunology 2009, 46:2794-2800.
-
(2009)
Molecular Immunology
, vol.46
, pp. 2794-2800
-
-
Gancz, D.1
Fishelson, Z.2
-
30
-
-
0017102972
-
The complement system in tumor immunity: significance of elevated levels of complement in tumor bearing hosts
-
Nishioka K., Kawamura K., Hirayama T., Kawashima T., Shimada K. The complement system in tumor immunity: significance of elevated levels of complement in tumor bearing hosts. Annals of the New York Academy of Sciences 1976, 276:303-315.
-
(1976)
Annals of the New York Academy of Sciences
, vol.276
, pp. 303-315
-
-
Nishioka, K.1
Kawamura, K.2
Hirayama, T.3
Kawashima, T.4
Shimada, K.5
-
31
-
-
0017661843
-
Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases
-
Maness P.F., Orengo A. Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases. Oncology 1977, 34:87-89.
-
(1977)
Oncology
, vol.34
, pp. 87-89
-
-
Maness, P.F.1
Orengo, A.2
-
32
-
-
0026437987
-
Immunoglobulins and complement components levels in patients with lung cancer
-
Gminski J., Mykala-Ciesla J., Machalski M., Drozdz M., Najda J. Immunoglobulins and complement components levels in patients with lung cancer. Romanian Journal of Internal Medicine 1992, 30:39-44.
-
(1992)
Romanian Journal of Internal Medicine
, vol.30
, pp. 39-44
-
-
Gminski, J.1
Mykala-Ciesla, J.2
Machalski, M.3
Drozdz, M.4
Najda, J.5
-
33
-
-
3142678924
-
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer
-
Ytting H., Jensenius J.C., Christensen I.J., Thiel S., Nielsen H.J. Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scandinavian Journal of Gastroenterology 2004, 39:674-679.
-
(2004)
Scandinavian Journal of Gastroenterology
, vol.39
, pp. 674-679
-
-
Ytting, H.1
Jensenius, J.C.2
Christensen, I.J.3
Thiel, S.4
Nielsen, H.J.5
-
34
-
-
16244406519
-
Ascitic complement system in ovarian cancer
-
Bjorge L., Hakulinen J., Vintermyr O.K., Jarva H., Jensen T.S., Iversen O.E., et al. Ascitic complement system in ovarian cancer. British Journal of Cancer 2005, 92:895-905.
-
(2005)
British Journal of Cancer
, vol.92
, pp. 895-905
-
-
Bjorge, L.1
Hakulinen, J.2
Vintermyr, O.K.3
Jarva, H.4
Jensen, T.S.5
Iversen, O.E.6
-
35
-
-
84867919350
-
Anaphylatoxin c5a creates a favorable microenvironment for lung cancer progression
-
Corrales L., Ajona D., Rafail S., Lasarte J.J., Riezu-Boj J.I., Lambris J.D., et al. Anaphylatoxin c5a creates a favorable microenvironment for lung cancer progression. Journal of Immunology 2012, 189:4674-4683.
-
(2012)
Journal of Immunology
, vol.189
, pp. 4674-4683
-
-
Corrales, L.1
Ajona, D.2
Rafail, S.3
Lasarte, J.J.4
Riezu-Boj, J.I.5
Lambris, J.D.6
-
36
-
-
54549109936
-
Modulation of the antitumor immune response by complement
-
Markiewski M.M., DeAngelis R.A., Benencia F., Ricklin-Lichtsteiner S.K., Koutoulaki A., Gerard C., et al. Modulation of the antitumor immune response by complement. Nature Immunology 2008, 9:1225-1235.
-
(2008)
Nature Immunology
, vol.9
, pp. 1225-1235
-
-
Markiewski, M.M.1
DeAngelis, R.A.2
Benencia, F.3
Ricklin-Lichtsteiner, S.K.4
Koutoulaki, A.5
Gerard, C.6
-
37
-
-
0023158833
-
C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance
-
Fust G., Miszlay Z., Czink E., Varga L., Paloczi K., Szegedi G., et al. C1 and C4 abnormalities in chronic lymphocytic leukaemia and their significance. Immunology Letters 1987, 14:255-259.
-
(1987)
Immunology Letters
, vol.14
, pp. 255-259
-
-
Fust, G.1
Miszlay, Z.2
Czink, E.3
Varga, L.4
Paloczi, K.5
Szegedi, G.6
-
38
-
-
0029783494
-
The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives
-
Schlesinger M., Broman I., Lugassy G. The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives. Leukemia 1996, 10:1509-1513.
-
(1996)
Leukemia
, vol.10
, pp. 1509-1513
-
-
Schlesinger, M.1
Broman, I.2
Lugassy, G.3
-
39
-
-
0017286889
-
Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis
-
Budzko D.B., Lachmann P.J., McConnell I. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis. Cellular Immunology 1976, 22:98-109.
-
(1976)
Cellular Immunology
, vol.22
, pp. 98-109
-
-
Budzko, D.B.1
Lachmann, P.J.2
McConnell, I.3
-
40
-
-
0017256415
-
Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes
-
Theofilopoulos A.N., Perrin L.H. Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes. Journal of Experimental Medicine 1976, 143:271-289.
-
(1976)
Journal of Experimental Medicine
, vol.143
, pp. 271-289
-
-
Theofilopoulos, A.N.1
Perrin, L.H.2
-
41
-
-
0019842492
-
Alternative pathway of complement in multiple myeloma
-
Kraut E.H., Sagone A.L. Alternative pathway of complement in multiple myeloma. American Journal of Hematology 1981, 11:335-345.
-
(1981)
American Journal of Hematology
, vol.11
, pp. 335-345
-
-
Kraut, E.H.1
Sagone, A.L.2
-
42
-
-
0017085328
-
Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia
-
Kalwinsky D.K., Urmson J.R., Stitzel A.E., Spitzer R.E. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia. Journal of Laboratory and Clinical Medicine 1976, 88:745-756.
-
(1976)
Journal of Laboratory and Clinical Medicine
, vol.88
, pp. 745-756
-
-
Kalwinsky, D.K.1
Urmson, J.R.2
Stitzel, A.E.3
Spitzer, R.E.4
-
43
-
-
0036840236
-
Generation of C5a by phagocytic cells
-
Huber-Lang M., Younkin E.M., Sarma J.V., Riedemann N., McGuire S.R., Lu K.T., et al. Generation of C5a by phagocytic cells. American Journal of Pathology 2002, 161:1849-1859.
-
(2002)
American Journal of Pathology
, vol.161
, pp. 1849-1859
-
-
Huber-Lang, M.1
Younkin, E.M.2
Sarma, J.V.3
Riedemann, N.4
McGuire, S.R.5
Lu, K.T.6
-
44
-
-
33744987414
-
Generation of C5a in the absence of C3: a new complement activation pathway
-
Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nature Medicine 2006, 12:682-687.
-
(2006)
Nature Medicine
, vol.12
, pp. 682-687
-
-
Huber-Lang, M.1
Sarma, J.V.2
Zetoune, F.S.3
Rittirsch, D.4
Neff, T.A.5
McGuire, S.R.6
-
45
-
-
33947602404
-
Complement and coagulation: strangers or partners in crime?
-
Markiewski M.M., Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. Complement and coagulation: strangers or partners in crime?. Trends in Immunology 2007, 28:184-192.
-
(2007)
Trends in Immunology
, vol.28
, pp. 184-192
-
-
Markiewski, M.M.1
Nilsson, B.2
Ekdahl, K.N.3
Mollnes, T.E.4
Lambris, J.D.5
-
46
-
-
58149349888
-
Interaction between the coagulation and complement system
-
Amara U., Rittirsch D., Flierl M., Bruckner U., Klos A., Gebhard F., et al. Interaction between the coagulation and complement system. Advances in Experimental Medicine and Biology 2008, 632:71-79.
-
(2008)
Advances in Experimental Medicine and Biology
, vol.632
, pp. 71-79
-
-
Amara, U.1
Rittirsch, D.2
Flierl, M.3
Bruckner, U.4
Klos, A.5
Gebhard, F.6
-
47
-
-
7644229013
-
Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients
-
Ramos-Casals M., Campoamor M.T., Chamorro A., Salvador G., Segura S., Botero J.C., et al. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients. Lupus 2004, 13:777-783.
-
(2004)
Lupus
, vol.13
, pp. 777-783
-
-
Ramos-Casals, M.1
Campoamor, M.T.2
Chamorro, A.3
Salvador, G.4
Segura, S.5
Botero, J.C.6
-
48
-
-
33947608775
-
Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events
-
Palikhe A., Sinisalo J., Seppanen M., Haario H., Meri S., Valtonen V., et al. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events. American Journal of Cardiology 2007, 99:890-895.
-
(2007)
American Journal of Cardiology
, vol.99
, pp. 890-895
-
-
Palikhe, A.1
Sinisalo, J.2
Seppanen, M.3
Haario, H.4
Meri, S.5
Valtonen, V.6
-
49
-
-
77953323242
-
The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma
-
Kanmura S., Uto H., Sato Y., Kumagai K., Sasaki F., Moriuchi A., et al. The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. Journal of Gastroenterology 2010, 45:459-467.
-
(2010)
Journal of Gastroenterology
, vol.45
, pp. 459-467
-
-
Kanmura, S.1
Uto, H.2
Sato, Y.3
Kumagai, K.4
Sasaki, F.5
Moriuchi, A.6
-
50
-
-
0018649570
-
Fluctuation of serum complement levels in children with neuroblastoma
-
Carli M., Bucolo C., Pannunzio M.T., Ongaro G., Businaro R., Revoltella R. Fluctuation of serum complement levels in children with neuroblastoma. Cancer 1979, 43:2399-2404.
-
(1979)
Cancer
, vol.43
, pp. 2399-2404
-
-
Carli, M.1
Bucolo, C.2
Pannunzio, M.T.3
Ongaro, G.4
Businaro, R.5
Revoltella, R.6
-
51
-
-
0028941263
-
Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia
-
Varga L., Czink E., Miszlai Z., Paloczi K., Banyai A., Szegedi G., et al. Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia. Clinical and Experimental Immunology 1995, 99:112-116.
-
(1995)
Clinical and Experimental Immunology
, vol.99
, pp. 112-116
-
-
Varga, L.1
Czink, E.2
Miszlai, Z.3
Paloczi, K.4
Banyai, A.5
Szegedi, G.6
-
52
-
-
14644445180
-
Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality
-
Ytting H., Christensen I.J., Thiel S., Jensenius J.C., Nielsen H.J. Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: relation to recurrence and mortality. Clinical Cancer Research 2005, 11:1441-1446.
-
(2005)
Clinical Cancer Research
, vol.11
, pp. 1441-1446
-
-
Ytting, H.1
Christensen, I.J.2
Thiel, S.3
Jensenius, J.C.4
Nielsen, H.J.5
-
53
-
-
0142042497
-
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients
-
Durrant L.G., Chapman M.A., Buckley D.J., Spendlove I., Robins R.A., Armitage N.C. Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunology, Immunotherapy 2003, 52:638-642.
-
(2003)
Cancer Immunology, Immunotherapy
, vol.52
, pp. 638-642
-
-
Durrant, L.G.1
Chapman, M.A.2
Buckley, D.J.3
Spendlove, I.4
Robins, R.A.5
Armitage, N.C.6
-
54
-
-
12344294466
-
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy
-
Xu C., Jung M., Burkhardt M., Stephan C., Schnorr D., Loening S., et al. Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy. Prostate 2005, 62:224-232.
-
(2005)
Prostate
, vol.62
, pp. 224-232
-
-
Xu, C.1
Jung, M.2
Burkhardt, M.3
Stephan, C.4
Schnorr, D.5
Loening, S.6
-
55
-
-
33646369422
-
Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients
-
Watson N.F., Durrant L.G., Madjd Z., Ellis I.O., Scholefield J.H., Spendlove I. Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients. Cancer Immunology, Immunotherapy 2006, 55:973-980.
-
(2006)
Cancer Immunology, Immunotherapy
, vol.55
, pp. 973-980
-
-
Watson, N.F.1
Durrant, L.G.2
Madjd, Z.3
Ellis, I.O.4
Scholefield, J.H.5
Spendlove, I.6
-
56
-
-
77957999549
-
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value
-
Michlmayr A., Bachleitner-Hofmann T., Baumann S., Marchetti-Deschmann M., Rech-Weichselbraun I., Burghuber C., et al. Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value. British Journal of Cancer 2011, 103:1201-1208.
-
(2011)
British Journal of Cancer
, vol.103
, pp. 1201-1208
-
-
Michlmayr, A.1
Bachleitner-Hofmann, T.2
Baumann, S.3
Marchetti-Deschmann, M.4
Rech-Weichselbraun, I.5
Burghuber, C.6
-
57
-
-
0016669835
-
Humoral immunostimulation. IV. Role of complement
-
Shearer W.T., Atkinson J.P., Frank M.M., Parker C.W. Humoral immunostimulation. IV. Role of complement. Journal of Experimental Medicine 1975, 141:736-752.
-
(1975)
Journal of Experimental Medicine
, vol.141
, pp. 736-752
-
-
Shearer, W.T.1
Atkinson, J.P.2
Frank, M.M.3
Parker, C.W.4
-
59
-
-
84869189833
-
Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization
-
Nunez-Cruz S., Gimotty P.A., Guerra M.W., Connolly D.C., Wu Y.Q., Deangelis R.A., et al. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization. Neoplasia 2012, 14:994-1004.
-
(2012)
Neoplasia
, vol.14
, pp. 994-1004
-
-
Nunez-Cruz, S.1
Gimotty, P.A.2
Guerra, M.W.3
Connolly, D.C.4
Wu, Y.Q.5
Deangelis, R.A.6
-
60
-
-
84866149234
-
Opposing roles for complement component C5a in tumor progression and the tumor microenvironment
-
Gunn L., Ding C., Liu M., Ma Y., Qi C., Cai Y., et al. Opposing roles for complement component C5a in tumor progression and the tumor microenvironment. Journal of Immunology 2012, 189:2985-2994.
-
(2012)
Journal of Immunology
, vol.189
, pp. 2985-2994
-
-
Gunn, L.1
Ding, C.2
Liu, M.3
Ma, Y.4
Qi, C.5
Cai, Y.6
-
61
-
-
33646755569
-
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity
-
Smyth M.J., Dunn G.P., Schreiber R.D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Advances in Immunology 2006, 90:1-50.
-
(2006)
Advances in Immunology
, vol.90
, pp. 1-50
-
-
Smyth, M.J.1
Dunn, G.P.2
Schreiber, R.D.3
-
62
-
-
33947214949
-
Immunotherapeutic strategies for high-risk bladder cancer
-
Sharma P., Old L.J., Allison J.P. Immunotherapeutic strategies for high-risk bladder cancer. Seminars in Oncology 2007, 34:165-172.
-
(2007)
Seminars in Oncology
, vol.34
, pp. 165-172
-
-
Sharma, P.1
Old, L.J.2
Allison, J.P.3
-
63
-
-
84879076366
-
The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy
-
Lanca T., Silva-Santos B. The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy. Oncoimmunology 2012, 1:717-725.
-
(2012)
Oncoimmunology
, vol.1
, pp. 717-725
-
-
Lanca, T.1
Silva-Santos, B.2
-
64
-
-
48749097847
-
Expression of galectin-3 in the tumor immune response in colon cancer
-
Dumont P., Berton A., Nagy N., Sandras F., Tinton S., Demetter P., et al. Expression of galectin-3 in the tumor immune response in colon cancer. Laboratory Investigation 2008, 88:896-906.
-
(2008)
Laboratory Investigation
, vol.88
, pp. 896-906
-
-
Dumont, P.1
Berton, A.2
Nagy, N.3
Sandras, F.4
Tinton, S.5
Demetter, P.6
-
65
-
-
84855219213
-
Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response
-
Ong S.M., Tan Y.C., Beretta O., Jiang D., Yeap W.H., Tai J.J., et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. European Journal of Immunology 2012, 42:89-100.
-
(2012)
European Journal of Immunology
, vol.42
, pp. 89-100
-
-
Ong, S.M.1
Tan, Y.C.2
Beretta, O.3
Jiang, D.4
Yeap, W.H.5
Tai, J.J.6
-
66
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
67
-
-
47949096781
-
Cancer-related inflammation
-
Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
-
(2008)
Nature
, vol.454
, pp. 436-444
-
-
Mantovani, A.1
Allavena, P.2
Sica, A.3
Balkwill, F.4
-
68
-
-
4444337741
-
Epidemiology of environmental and occupational cancer
-
Boffetta P. Epidemiology of environmental and occupational cancer. Oncogene 2004, 23:6392-6403.
-
(2004)
Oncogene
, vol.23
, pp. 6392-6403
-
-
Boffetta, P.1
-
70
-
-
84875968524
-
Complement in immune and inflammatory disorders: pathophysiological mechanisms
-
Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. Journal of Immunology 2013, 190:3831-3838.
-
(2013)
Journal of Immunology
, vol.190
, pp. 3831-3838
-
-
Ricklin, D.1
Lambris, J.D.2
-
73
-
-
0028855946
-
Eicosanoids and histamine mediate C5a-induced electrolyte secretion in guinea pig ileal mucosa
-
Kachur J.F., Won-Kim S., Anglin C., Gaginella T.S. Eicosanoids and histamine mediate C5a-induced electrolyte secretion in guinea pig ileal mucosa. Inflammation 1995, 19:717-725.
-
(1995)
Inflammation
, vol.19
, pp. 717-725
-
-
Kachur, J.F.1
Won-Kim, S.2
Anglin, C.3
Gaginella, T.S.4
-
74
-
-
84861078831
-
A review: inflammatory process in Alzheimer's disease, role of cytokines
-
Rubio-Perez J.M., Morillas-Ruiz J.M. A review: inflammatory process in Alzheimer's disease, role of cytokines. The Scientific World Journal 2012, 2012:756357.
-
(2012)
The Scientific World Journal
, vol.2012
, pp. 756357
-
-
Rubio-Perez, J.M.1
Morillas-Ruiz, J.M.2
-
75
-
-
80051672429
-
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors
-
Ballanti E., Perricone C., di Muzio G., Kroegler B., Chimenti M.S., Graceffa D., et al. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors. Autoimmunity Reviews 2011, 10:617-623.
-
(2011)
Autoimmunity Reviews
, vol.10
, pp. 617-623
-
-
Ballanti, E.1
Perricone, C.2
di Muzio, G.3
Kroegler, B.4
Chimenti, M.S.5
Graceffa, D.6
-
76
-
-
78649647356
-
Cancer and the complement cascade
-
Rutkowski M.J., Sughrue M.E., Kane A.J., Mills S.A., Parsa A.T. Cancer and the complement cascade. Molecular Cancer Research 2010, 8:1453-1465.
-
(2010)
Molecular Cancer Research
, vol.8
, pp. 1453-1465
-
-
Rutkowski, M.J.1
Sughrue, M.E.2
Kane, A.J.3
Mills, S.A.4
Parsa, A.T.5
-
77
-
-
66949144423
-
The regulation of liver cell survival by complement
-
Markiewski M.M., DeAngelis R.A., Strey C.W., Foukas P.G., Gerard C., Gerard N., et al. The regulation of liver cell survival by complement. Journal of Immunology 2009, 182:5412-5418.
-
(2009)
Journal of Immunology
, vol.182
, pp. 5412-5418
-
-
Markiewski, M.M.1
DeAngelis, R.A.2
Strey, C.W.3
Foukas, P.G.4
Gerard, C.5
Gerard, N.6
-
78
-
-
84865422083
-
Interleukin-6 signaling pathway in targeted therapy for cancer
-
Guo Y., Xu F., Lu T., Duan Z., Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treatment Reviews 2012, 38:904-910.
-
(2012)
Cancer Treatment Reviews
, vol.38
, pp. 904-910
-
-
Guo, Y.1
Xu, F.2
Lu, T.3
Duan, Z.4
Zhang, Z.5
-
79
-
-
0033011634
-
Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression
-
Sayah S., Ischenko A.M., Zhakhov A., Bonnard A.S., Fontaine M. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression. Journal of Neurochemistry 1999, 72:2426-2436.
-
(1999)
Journal of Neurochemistry
, vol.72
, pp. 2426-2436
-
-
Sayah, S.1
Ischenko, A.M.2
Zhakhov, A.3
Bonnard, A.S.4
Fontaine, M.5
-
80
-
-
10844231850
-
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization
-
Bora P.S., Sohn J.H., Cruz J.M., Jha P., Nishihori H., Wang Y., et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. Journal of Immunology 2005, 174:491-497.
-
(2005)
Journal of Immunology
, vol.174
, pp. 491-497
-
-
Bora, P.S.1
Sohn, J.H.2
Cruz, J.M.3
Jha, P.4
Nishihori, H.5
Wang, Y.6
-
81
-
-
39749202804
-
Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9
-
Gionanlis L., Alexopoulos E., Papagianni A., Leontsini M., Memmos D. Fibrotic mechanisms in idiopathic rapidly progressive glomerulonephritis: the role of TGF-beta1 and C5b-9. Renal Failure 2008, 30:239-246.
-
(2008)
Renal Failure
, vol.30
, pp. 239-246
-
-
Gionanlis, L.1
Alexopoulos, E.2
Papagianni, A.3
Leontsini, M.4
Memmos, D.5
-
83
-
-
84875189381
-
Molecular pathways: toll-like receptors in the tumor microenvironment-poor prognosis or new therapeutic opportunity
-
Ridnour L.A., Cheng R.Y., Switzer C.H., Heinecke J.L., Ambs S., Glynn S., et al. Molecular pathways: toll-like receptors in the tumor microenvironment-poor prognosis or new therapeutic opportunity. Clinical Cancer Research 2013, 19:1340-1346.
-
(2013)
Clinical Cancer Research
, vol.19
, pp. 1340-1346
-
-
Ridnour, L.A.1
Cheng, R.Y.2
Switzer, C.H.3
Heinecke, J.L.4
Ambs, S.5
Glynn, S.6
-
84
-
-
34347400796
-
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo
-
Zhang X., Kimura Y., Fang C., Zhou L., Sfyroera G., Lambris J.D., et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007, 110:228-236.
-
(2007)
Blood
, vol.110
, pp. 228-236
-
-
Zhang, X.1
Kimura, Y.2
Fang, C.3
Zhou, L.4
Sfyroera, G.5
Lambris, J.D.6
-
86
-
-
70349786130
-
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack
-
Okroj M., Corrales L., Stokowska A., Pio R., Blom A.M. Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack. Cancer Immunology, Immunotherapy 2009, 58:1771-1780.
-
(2009)
Cancer Immunology, Immunotherapy
, vol.58
, pp. 1771-1780
-
-
Okroj, M.1
Corrales, L.2
Stokowska, A.3
Pio, R.4
Blom, A.M.5
-
89
-
-
41149164902
-
The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance
-
Allavena P., Sica A., Garlanda C., Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunological Reviews 2008, 222:155-161.
-
(2008)
Immunological Reviews
, vol.222
, pp. 155-161
-
-
Allavena, P.1
Sica, A.2
Garlanda, C.3
Mantovani, A.4
-
92
-
-
84872559040
-
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
-
Lindau D., Gielen P., Kroesen M., Wesseling P., Adema G.J. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 2013, 138:105-115.
-
(2013)
Immunology
, vol.138
, pp. 105-115
-
-
Lindau, D.1
Gielen, P.2
Kroesen, M.3
Wesseling, P.4
Adema, G.J.5
-
93
-
-
5444259851
-
The complement system in regulation of adaptive immunity
-
Carroll M.C. The complement system in regulation of adaptive immunity. Nature Immunology 2004, 5:981-986.
-
(2004)
Nature Immunology
, vol.5
, pp. 981-986
-
-
Carroll, M.C.1
-
94
-
-
0036104834
-
Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection
-
Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nature Medicine 2002, 8:373-378.
-
(2002)
Nature Medicine
, vol.8
, pp. 373-378
-
-
Kopf, M.1
Abel, B.2
Gallimore, A.3
Carroll, M.4
Bachmann, M.F.5
-
95
-
-
4043077003
-
Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses
-
Kim A.H., Dimitriou I.D., Holland M.C., Mastellos D., Mueller Y.M., Altman J.D., et al. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. Journal of Immunology 2004, 173:2524-2529.
-
(2004)
Journal of Immunology
, vol.173
, pp. 2524-2529
-
-
Kim, A.H.1
Dimitriou, I.D.2
Holland, M.C.3
Mastellos, D.4
Mueller, Y.M.5
Altman, J.D.6
-
96
-
-
49749103028
-
Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice
-
Fang C., Miwa T., Shen H., Song W.C. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. Journal of Immunology 2007, 179:3178-3186.
-
(2007)
Journal of Immunology
, vol.179
, pp. 3178-3186
-
-
Fang, C.1
Miwa, T.2
Shen, H.3
Song, W.C.4
-
97
-
-
41349100253
-
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction
-
Peng Q., Li K., Anderson K., Farrar C.A., Lu B., Smith R.A., et al. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008, 111:2452-2461.
-
(2008)
Blood
, vol.111
, pp. 2452-2461
-
-
Peng, Q.1
Li, K.2
Anderson, K.3
Farrar, C.A.4
Lu, B.5
Smith, R.A.6
-
98
-
-
58149393171
-
Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation
-
Li K., Anderson K.J., Peng Q., Noble A., Lu B., Kelly A.P., et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 2008, 112:5084-5094.
-
(2008)
Blood
, vol.112
, pp. 5084-5094
-
-
Li, K.1
Anderson, K.J.2
Peng, Q.3
Noble, A.4
Lu, B.5
Kelly, A.P.6
-
99
-
-
84874562997
-
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells
-
Kwan W.H., van der Touw W., Paz-Artal E., Li M.O., Heeger P.S. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. Journal of Experimental Medicine 2013, 210:257-268.
-
(2013)
Journal of Experimental Medicine
, vol.210
, pp. 257-268
-
-
Kwan, W.H.1
van der Touw, W.2
Paz-Artal, E.3
Li, M.O.4
Heeger, P.S.5
-
100
-
-
84872681454
-
Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells
-
Strainic M.G., Shevach E.M., An F., Lin F., Medof M.E. Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells. Nature Immunology 2013, 14:162-171.
-
(2013)
Nature Immunology
, vol.14
, pp. 162-171
-
-
Strainic, M.G.1
Shevach, E.M.2
An, F.3
Lin, F.4
Medof, M.E.5
-
101
-
-
0347895101
-
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
-
Kemper C., Chan A.C., Green J.M., Brett K.A., Murphy K.M., Atkinson J.P. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
-
(2003)
Nature
, vol.421
, pp. 388-392
-
-
Kemper, C.1
Chan, A.C.2
Green, J.M.3
Brett, K.A.4
Murphy, K.M.5
Atkinson, J.P.6
-
102
-
-
0037324434
-
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
-
Sohn J.H., Bora P.S., Suk H.J., Molina H., Kaplan H.J., Bora N.S. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nature Medicine 2003, 9:206-212.
-
(2003)
Nature Medicine
, vol.9
, pp. 206-212
-
-
Sohn, J.H.1
Bora, P.S.2
Suk, H.J.3
Molina, H.4
Kaplan, H.J.5
Bora, N.S.6
-
103
-
-
84876460778
-
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells
-
Hsieh C.C., Chou H.S., Yang H.R., Lin F., Bhatt S., Qin J., et al. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 2013, 121:1760-1768.
-
(2013)
Blood
, vol.121
, pp. 1760-1768
-
-
Hsieh, C.C.1
Chou, H.S.2
Yang, H.R.3
Lin, F.4
Bhatt, S.5
Qin, J.6
-
105
-
-
84866849940
-
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment
-
Schneider B.P., Shen F., Miller K.D. Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment. Lancet Oncology 2012, 13:e427-e436.
-
(2012)
Lancet Oncology
, vol.13
-
-
Schneider, B.P.1
Shen, F.2
Miller, K.D.3
-
106
-
-
78649482676
-
Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis
-
Langer H.F., Chung K.J., Orlova V.V., Choi E.Y., Kaul S., Kruhlak M.J., et al. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 2010, 116:4395-4403.
-
(2010)
Blood
, vol.116
, pp. 4395-4403
-
-
Langer, H.F.1
Chung, K.J.2
Orlova, V.V.3
Choi, E.Y.4
Kaul, S.5
Kruhlak, M.J.6
-
107
-
-
33748450585
-
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
-
Girardi G., Yarilin D., Thurman J.M., Holers V.M., Salmon J.E. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. Journal of Experimental Medicine 2006, 203:2165-2175.
-
(2006)
Journal of Experimental Medicine
, vol.203
, pp. 2165-2175
-
-
Girardi, G.1
Yarilin, D.2
Thurman, J.M.3
Holers, V.M.4
Salmon, J.E.5
-
108
-
-
77955658951
-
C5a promotes migration, proliferation, and vessel formation in endothelial cells
-
Kurihara R., Yamaoka K., Sawamukai N., Shimajiri S., Oshita K., Yukawa S., et al. C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflammation Research 2010, 59:659-666.
-
(2010)
Inflammation Research
, vol.59
, pp. 659-666
-
-
Kurihara, R.1
Yamaoka, K.2
Sawamukai, N.3
Shimajiri, S.4
Oshita, K.5
Yukawa, S.6
-
109
-
-
0037103283
-
Complement c3a and c5a induce different signal transduction cascades in endothelial cells
-
Schraufstatter I.U., Trieu K., Sikora L., Sriramarao P., DiScipio R. Complement c3a and c5a induce different signal transduction cascades in endothelial cells. Journal of Immunology 2002, 169:2102-2110.
-
(2002)
Journal of Immunology
, vol.169
, pp. 2102-2110
-
-
Schraufstatter, I.U.1
Trieu, K.2
Sikora, L.3
Sriramarao, P.4
DiScipio, R.5
-
110
-
-
1242293775
-
C5a-induced gene expression in human umbilical vein endothelial cells
-
Albrecht E.A., Chinnaiyan A.M., Varambally S., Kumar-Sinha C., Barrette T.R., Sarma J.V., et al. C5a-induced gene expression in human umbilical vein endothelial cells. American Journal of Pathology 2004, 164:849-859.
-
(2004)
American Journal of Pathology
, vol.164
, pp. 849-859
-
-
Albrecht, E.A.1
Chinnaiyan, A.M.2
Varambally, S.3
Kumar-Sinha, C.4
Barrette, T.R.5
Sarma, J.V.6
-
111
-
-
33144488589
-
Drusen complement components C3a and C5a promote choroidal neovascularization
-
Nozaki M., Raisler B.J., Sakurai E., Sarma J.V., Barnum S.R., Lambris J.D., et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:2328-2333.
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, pp. 2328-2333
-
-
Nozaki, M.1
Raisler, B.J.2
Sakurai, E.3
Sarma, J.V.4
Barnum, S.R.5
Lambris, J.D.6
-
112
-
-
20244380171
-
Complement factor H polymorphism in age-related macular degeneration
-
Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
-
(2005)
Science
, vol.308
, pp. 385-389
-
-
Klein, R.J.1
Zeiss, C.2
Chew, E.Y.3
Tsai, J.Y.4
Sackler, R.S.5
Haynes, C.6
-
113
-
-
33749143187
-
Complement factor H: spatial and temporal expression and localization in the eye
-
Mandal M.N., Ayyagari R. Complement factor H: spatial and temporal expression and localization in the eye. Investigative Ophthalmology and Visual Science 2006, 47:4091-4097.
-
(2006)
Investigative Ophthalmology and Visual Science
, vol.47
, pp. 4091-4097
-
-
Mandal, M.N.1
Ayyagari, R.2
-
114
-
-
0038693797
-
Beyond lysis: how complement influences cell fate
-
Cole D.S., Morgan B.P. Beyond lysis: how complement influences cell fate. Clinical Science (London) 2003, 104:455-466.
-
(2003)
Clinical Science (London)
, vol.104
, pp. 455-466
-
-
Cole, D.S.1
Morgan, B.P.2
-
115
-
-
84876367850
-
Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer
-
Vlaicu S.I., Tegla C.A., Cudrici C.D., Danoff J., Madani H., Sugarman A., et al. Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer. Immunologic Research 2013, 56:109-121.
-
(2013)
Immunologic Research
, vol.56
, pp. 109-121
-
-
Vlaicu, S.I.1
Tegla, C.A.2
Cudrici, C.D.3
Danoff, J.4
Madani, H.5
Sugarman, A.6
-
116
-
-
80053573431
-
Membrane attack by complement: the assembly and biology of terminal complement complexes
-
Tegla C.A., Cudrici C., Patel S., Trippe R., Rus V., Niculescu F., et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunologic Research 2011, 51:45-60.
-
(2011)
Immunologic Research
, vol.51
, pp. 45-60
-
-
Tegla, C.A.1
Cudrici, C.2
Patel, S.3
Trippe, R.4
Rus, V.5
Niculescu, F.6
-
117
-
-
0035069143
-
Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis
-
Kraus S., Seger R., Fishelson Z. Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Clinical and Experimental Immunology 2001, 123:366-374.
-
(2001)
Clinical and Experimental Immunology
, vol.123
, pp. 366-374
-
-
Kraus, S.1
Seger, R.2
Fishelson, Z.3
-
118
-
-
0032890247
-
Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase
-
Niculescu F., Badea T., Rus H. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 1999, 142:47-56.
-
(1999)
Atherosclerosis
, vol.142
, pp. 47-56
-
-
Niculescu, F.1
Badea, T.2
Rus, H.3
-
119
-
-
0031134091
-
Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent
-
Niculescu F., Rus H., van Biesen T., Shin M.L. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. Journal of Immunology 1997, 158:4405-4412.
-
(1997)
Journal of Immunology
, vol.158
, pp. 4405-4412
-
-
Niculescu, F.1
Rus, H.2
van Biesen, T.3
Shin, M.L.4
-
120
-
-
0032500522
-
Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes
-
Badea T.C., Niculescu F.I., Soane L., Shin M.L., Rus H. Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes. Journal of Biological Chemistry 1998, 273:26977-26981.
-
(1998)
Journal of Biological Chemistry
, vol.273
, pp. 26977-26981
-
-
Badea, T.C.1
Niculescu, F.I.2
Soane, L.3
Shin, M.L.4
Rus, H.5
-
121
-
-
0037016763
-
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase
-
Badea T., Niculescu F., Soane L., Fosbrink M., Sorana H., Rus V., et al. RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. Journal of Biological Chemistry 2002, 277:502-508.
-
(2002)
Journal of Biological Chemistry
, vol.277
, pp. 502-508
-
-
Badea, T.1
Niculescu, F.2
Soane, L.3
Fosbrink, M.4
Sorana, H.5
Rus, V.6
-
122
-
-
13844298274
-
Overexpression of RGC-32 in colon cancer and other tumors
-
Fosbrink M., Cudrici C., Niculescu F., Badea T.C., David S., Shamsuddin A., et al. Overexpression of RGC-32 in colon cancer and other tumors. Experimental and Molecular Pathology 2005, 78:116-122.
-
(2005)
Experimental and Molecular Pathology
, vol.78
, pp. 116-122
-
-
Fosbrink, M.1
Cudrici, C.2
Niculescu, F.3
Badea, T.C.4
David, S.5
Shamsuddin, A.6
-
123
-
-
84861994937
-
Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes
-
Naito A.T., Sumida T., Nomura S., Liu M.L., Higo T., Nakagawa A., et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 2012, 149:1298-1313.
-
(2012)
Cell
, vol.149
, pp. 1298-1313
-
-
Naito, A.T.1
Sumida, T.2
Nomura, S.3
Liu, M.L.4
Higo, T.5
Nakagawa, A.6
-
124
-
-
84871846692
-
WNT signalling pathways as therapeutic targets in cancer
-
Anastas J.N., Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nature Reviews Cancer 2013, 13:11-26.
-
(2013)
Nature Reviews Cancer
, vol.13
, pp. 11-26
-
-
Anastas, J.N.1
Moon, R.T.2
-
125
-
-
23844434887
-
G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK
-
la Sala A., Gadina M., Kelsall B.L. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. Journal of Immunology 2005, 175:2994-2999.
-
(2005)
Journal of Immunology
, vol.175
, pp. 2994-2999
-
-
la Sala, A.1
Gadina, M.2
Kelsall, B.L.3
-
126
-
-
34247643153
-
The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions
-
Wrann C.D., Tabriz N.A., Barkhausen T., Klos A., van Griensven M., Pape H.C., et al. The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions. Journal of Immunology 2007, 178:5940-5948.
-
(2007)
Journal of Immunology
, vol.178
, pp. 5940-5948
-
-
Wrann, C.D.1
Tabriz, N.A.2
Barkhausen, T.3
Klos, A.4
van Griensven, M.5
Pape, H.C.6
-
127
-
-
0035847643
-
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death
-
van Beek J., Nicole O., Ali C., Ischenko A., MacKenzie E.T., Buisson A., et al. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport 2001, 12:289-293.
-
(2001)
Neuroreport
, vol.12
, pp. 289-293
-
-
van Beek, J.1
Nicole, O.2
Ali, C.3
Ischenko, A.4
MacKenzie, E.T.5
Buisson, A.6
-
128
-
-
0035076597
-
Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3
-
Mukherjee P., Pasinetti G.M. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. Journal of Neurochemistry 2001, 77:43-49.
-
(2001)
Journal of Neurochemistry
, vol.77
, pp. 43-49
-
-
Mukherjee, P.1
Pasinetti, G.M.2
-
129
-
-
4344686677
-
Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat
-
Daveau M., Benard M., Scotte M., Schouft M.T., Hiron M., Francois A., et al. Expression of a functional C5a receptor in regenerating hepatocytes and its involvement in a proliferative signaling pathway in rat. Journal of Immunology 2004, 173:3418-3424.
-
(2004)
Journal of Immunology
, vol.173
, pp. 3418-3424
-
-
Daveau, M.1
Benard, M.2
Scotte, M.3
Schouft, M.T.4
Hiron, M.5
Francois, A.6
-
130
-
-
65249122512
-
Novel therapeutic inhibitors of the c-Met signaling pathway in cancer
-
Eder J.P., Vande Woude G.F., Boerner S.A., LoRusso P.M. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clinical Cancer Research 2009, 15:2207-2214.
-
(2009)
Clinical Cancer Research
, vol.15
, pp. 2207-2214
-
-
Eder, J.P.1
Vande Woude, G.F.2
Boerner, S.A.3
LoRusso, P.M.4
-
131
-
-
0029885318
-
Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors
-
Jiang H., Kuang Y., Wu Y., Smrcka A., Simon M.I., Wu D. Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors. Journal of Biological Chemistry 1996, 271:13430-13434.
-
(1996)
Journal of Biological Chemistry
, vol.271
, pp. 13430-13434
-
-
Jiang, H.1
Kuang, Y.2
Wu, Y.3
Smrcka, A.4
Simon, M.I.5
Wu, D.6
-
132
-
-
0025348474
-
Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides
-
Mullmann T.J., Siegel M.I., Egan R.W., Billah M.M. Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides. Journal of Immunology 1990, 144:1901-1908.
-
(1990)
Journal of Immunology
, vol.144
, pp. 1901-1908
-
-
Mullmann, T.J.1
Siegel, M.I.2
Egan, R.W.3
Billah, M.M.4
-
133
-
-
68549140332
-
Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
-
Linardou H., Dahabreh I.J., Bafaloukos D., Kosmidis P., Murray S. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. Nature Reviews Clinical Oncology 2009, 6:352-366.
-
(2009)
Nature Reviews Clinical Oncology
, vol.6
, pp. 352-366
-
-
Linardou, H.1
Dahabreh, I.J.2
Bafaloukos, D.3
Kosmidis, P.4
Murray, S.5
-
134
-
-
4344689094
-
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement
-
Ajona D., Castano Z., Garayoa M., Zudaire E., Pajares M.J., Martinez A., et al. Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Research 2004, 64:6310-6318.
-
(2004)
Cancer Research
, vol.64
, pp. 6310-6318
-
-
Ajona, D.1
Castano, Z.2
Garayoa, M.3
Zudaire, E.4
Pajares, M.J.5
Martinez, A.6
-
135
-
-
34247585574
-
Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth
-
Ajona D., Hsu Y.F., Corrales L., Montuenga L.M., Pio R. Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth. Journal of Immunology 2007, 178:5991-5998.
-
(2007)
Journal of Immunology
, vol.178
, pp. 5991-5998
-
-
Ajona, D.1
Hsu, Y.F.2
Corrales, L.3
Montuenga, L.M.4
Pio, R.5
-
136
-
-
77953046198
-
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
-
Hsu Y.F., Ajona D., Corrales L., Lopez-Picazo J.M., Gurpide A., Montuenga L.M., et al. Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo. Molecular Cancer 2010, 9:139.
-
(2010)
Molecular Cancer
, vol.9
, pp. 139
-
-
Hsu, Y.F.1
Ajona, D.2
Corrales, L.3
Lopez-Picazo, J.M.4
Gurpide, A.5
Montuenga, L.M.6
-
137
-
-
33845514506
-
Drug evaluation: the C5a receptor antagonist PMX-53
-
Kohl J. Drug evaluation: the C5a receptor antagonist PMX-53. Current Opinion in Molecular Therapeutics 2006, 8:529-538.
-
(2006)
Current Opinion in Molecular Therapeutics
, vol.8
, pp. 529-538
-
-
Kohl, J.1
-
138
-
-
84875990477
-
Complement in immune and inflammatory disorders: therapeutic interventions
-
Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: therapeutic interventions. Journal of Immunology 2013, 190:3839-3847.
-
(2013)
Journal of Immunology
, vol.190
, pp. 3839-3847
-
-
Ricklin, D.1
Lambris, J.D.2
-
141
-
-
78149481863
-
C1 inhibitor, a multi-functional serine protease inhibitor
-
Davis A.E., Lu F., Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor. Thrombosis and Haemostasis 2010, 104:886-893.
-
(2010)
Thrombosis and Haemostasis
, vol.104
, pp. 886-893
-
-
Davis, A.E.1
Lu, F.2
Mejia, P.3
-
143
-
-
0030013492
-
Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library
-
Sahu A., Kay B.K., Lambris J.D. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. Journal of Immunology 1996, 157:884-891.
-
(1996)
Journal of Immunology
, vol.157
, pp. 884-891
-
-
Sahu, A.1
Kay, B.K.2
Lambris, J.D.3
-
144
-
-
35748951604
-
Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition
-
Janssen B.J., Halff E.F., Lambris J.D., Gros P. Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition. Journal of Biological Chemistry 2007, 282:29241-29247.
-
(2007)
Journal of Biological Chemistry
, vol.282
, pp. 29241-29247
-
-
Janssen, B.J.1
Halff, E.F.2
Lambris, J.D.3
Gros, P.4
-
145
-
-
0037210289
-
Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3
-
Sahu A., Morikis D., Lambris J.D. Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3. Molecular Immunology 2003, 39:557-566.
-
(2003)
Molecular Immunology
, vol.39
, pp. 557-566
-
-
Sahu, A.1
Morikis, D.2
Lambris, J.D.3
-
146
-
-
84867741869
-
Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapies
-
Kempshall E., Thebault S., Morgan B.P., Harris C.L., Gallimore A. Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapies. Immunology and Cell Biology 2012, 90:869-871.
-
(2012)
Immunology and Cell Biology
, vol.90
, pp. 869-871
-
-
Kempshall, E.1
Thebault, S.2
Morgan, B.P.3
Harris, C.L.4
Gallimore, A.5
|